Healthcare >> Analyst Interviews >> February 21, 2013
Small and Midcap Medical Device Companies Benefit from Less Exposure to Europe
Steven M. Lichtman is Managing Director and Senior Analyst for medical devices at Oppenheimer & Co. Inc. Mr. Lichtman has been on the sell side following the medical devices sector for 20 years, including 17 years as a senior analyst. Prior to joining Oppenheimer to cover medical devices, he held that role at JMP Securities and Banc of America Securities. Prior to Banc of America, Mr. Lichtman was the Senior Associate on leading medical devices teams at Credit Suisse First Boston and Schroder & Company, Inc. Mr. Lichtman received a B.A. from Duke University in Economics and Public Policy Studies and an MBA from New York University’s Stern School of Business. Profile
TWST: Where are you focusing your attention in the medical device space these days?
Mr. Lichtman: I cover 15 stocks, both large- and small-cap companies, and the majority are small